Cardinal Health, Inc. $CAH Stock Holdings Raised by Nilsine Partners LLC

Nilsine Partners LLC grew its stake in Cardinal Health, Inc. (NYSE:CAH) by 437.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,049 shares of the company’s stock after purchasing an additional 4,924 shares during the quarter. Nilsine Partners LLC’s holdings in Cardinal Health were worth $1,437,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $26,000. Jones Financial Companies Lllp raised its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Bank of Jackson Hole Trust bought a new position in Cardinal Health during the fourth quarter worth $27,000. Palladiem LLC acquired a new position in Cardinal Health in the fourth quarter worth $28,000. Finally, Indiana Trust & Investment Management Co acquired a new position in Cardinal Health in the first quarter worth $29,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of CAH opened at $246.67 on Monday. The firm has a fifty day moving average of $234.23 and a 200-day moving average of $219.17. The company has a market cap of $57.37 billion, a price-to-earnings ratio of 34.12, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion for the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Analysts predict that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.8%. The ex-dividend date is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Robert W. Baird increased their target price on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th. Leerink Partners set a $292.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 11th. Zacks Research cut shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Finally, Barclays lifted their target price on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, August 13th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $266.56.

Insider Activity

In other news, insider Michelle Greene sold 11,650 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider directly owned 10,330 shares of the company’s stock, valued at approximately $2,434,987.60. This trade represents a 53.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jessica Mayer sold 29,436 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the sale, the insider owned 33,076 shares in the company, valued at approximately $7,812,220.44. This represents a 47.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 210,271 shares of company stock worth $49,626,657 over the last ninety days. 0.12% of the stock is currently owned by company insiders.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.